Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312000 | SCV000847065 | benign | Inborn genetic diseases | 2016-07-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001573077 | SCV001935454 | benign | not provided | 2020-09-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807043 | SCV002054221 | benign | Coffin-Siris syndrome 1 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001573077 | SCV002332504 | benign | not provided | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000114259 | SCV000147818 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Laboratory of Diagnostic Genome Analysis, |
RCV001573077 | SCV001798415 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000114259 | SCV001958122 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004542809 | SCV004791040 | benign | ARID1B-related disorder | 2019-04-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |